Home › Cases › Hypoglycaemia Unawareness
Hypoglycaemia
Hypoglycaemia Unawareness
6 questions
Question 1 · Hypoglycaemia unawareness
Correct answer: Hypoglycaemia unawareness — loss of warning symptoms from recurrent hypoglycaemia blunting autonomic response
Why
Hypoglycaemia unawareness: recurrent hypoglycaemia blunts the counterregulatory hormone response (glucagon, adrenaline, cortisol) and reduces cerebral symptom perception. Adrenergic warning symptoms (tremor, sweating, palpitations) no longer occur until neuroglycopenia is already established. Gold score ≥4 = impaired awareness.
Key point
Hypo unawareness: recurrent hypo → blunted counterregulation → no warning symptoms. Gold score ≥4. Silent neuroglycopenia.
Question 2 · Assessment
Correct answer: Gold score (single question: awareness 1=aware to 7=unaware), Clarke score, or Edinburgh hypoglycaemia scale. CGM for frequency assessment
Why
Hypoglycaemia unawareness assessment: Gold score (1 question 1-7 scale) — simple, widely used. Clarke score (8 questions). Edinburgh Hypoglycaemia Scale (more comprehensive). CGM provides objective data on time below range, frequency of hypoglycaemia, and nocturnal events.
Key point
Hypo unawareness: Gold score, Clarke score, Edinburgh scale. CGM for objective frequency. Gold score ≥4 = impaired awareness.
Question 3 · Management
Correct answer: Structured education (DAFNE), insulin/target review to avoid hypos, CGM with alarms, and specialist consideration of hybrid closed loop
Why
- Structured education: DAFNE and additional hypoglycaemia-awareness training
- Review insulin doses/regimen and overly low glucose targets, prioritising hypo avoidance; not blanket relaxation of agreed targets
- CGM with low-glucose alarms: NICE offers a choice of CGM to adults with T1DM, not only Gold ≥4
- Hybrid closed loop: consider with the specialist team under TA943; reduces risk but does not eliminate severe hypoglycaemia
- Persistent severe episodes despite these measures: specialist-centre review, including transplant assessment where appropriate
Key point
DAFNE/awareness education + insulin/target review + CGM alarms. Consider specialist hybrid closed loop; no guarantee that severe hypos disappear.
Question 4 · Closed-loop insulin delivery
Correct answer: CGM + insulin pump + algorithm adjusts insulin automatically; hybrid systems still need meal input and do not eliminate hypoglycaemia
Why
Hybrid closed loop: CGM sensor + insulin pump + control algorithm adjusts insulin delivery from sensor data; meal carbohydrate/bolus input is still needed. It improves time in range and can reduce hypoglycaemia, but is not a guarantee of no severe episodes. NICE TA943: adult T1DM with HbA1c ≥58 mmol/mol or disabling hypoglycaemia despite best management using pump and/or CGM, with specialist support and phased NHS implementation.
Key point
Hybrid closed loop = sensor + pump + algorithm, with meal input. TA943 eligibility and specialist support apply; hypoglycaemia remains possible.
Question 5 · Driving and hypoglycaemia
Correct answer: Stop driving and notify DVLA after this severe hypo at the wheel; assess awareness and licence group before any return
Why
After severe hypoglycaemia at the wheel: stop driving and notify DVLA. Mr Brown also has impaired awareness, which independently prevents driving.
- When eligible to drive again: check before starting and at least every 2 hours; carry glucose and a backup finger-prick meter
- Aim ≥5 mmol/L before driving; 4–5: take a carbohydrate snack; <4: treat the hypo
- After a hypo, do not resume until recovered and at least 45 minutes after glucose returns to ≥5
- Group 1: ≥2 severe episodes while awake in 12 months require notification/cessation; Group 2: any severe episode, including sleep
- DVLA decides licensing; device alarms do not replace adequate awareness
Key point
Severe hypo at the wheel or impaired awareness: stop driving + notify DVLA. When cleared: ≥5 before driving, two-hour checks, 45-minute post-hypo wait.
Question 6 · Islet cell transplant
Correct answer: Infusion of islet cells from donor pancreas into portal vein. Requires immunosuppression. NICE: indicated for severe hypoglycaemia unawareness failing all other treatments
Why
Islet cell transplant: donor pancreatic islets infused via portal vein → engraft in liver. Often requires 2-3 infusions from multiple donors. Lifelong immunosuppression needed. NICE: indicated for severe hypoglycaemia unawareness after failed CGM/closed-loop. 70-80% achieve insulin independence at 1 year (declines with time).
Key point
Islet transplant: donor islets infused into portal vein. Immunosuppression needed. 70-80% insulin-independent at 1yr. Severe hypo unawareness indication.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.